NATCOPHARM
מעודכן
NATCOPHARM
is Strong Performer development focused pharmaceutical company , today break 52w high with High volumes + high gain recorded .
This is my favorite chart pattern like "Cup and Handle " which is almost 80% successfully my side i believe on that for reached my targets' .
below some points of study for you like this ))-
Annual Revenue rose 37.57%, in the last year to Rs 2,811 Crores. Its sector's average revenue growth for the last fiscal year was 8.79%.
Company has been maintaining a healthy dividend payout of 28.0%
Holding :-
Promoter Holding :- 50%
FII :- 14%
DII :- 11 %
Public :- 25 %
give interim dividend
Ex-Date :- 26 Feb 2024
Dividend Amount :- 1.25
for MORE check in my TradingView ID
If You LIKE👌👌 MY Idea ......Boost.🔥🔥🔥.. its.
"Disclosure : I am not Sebi-registered." This channel is for only educational purpose. Any profit/loss, I am not responsible.
Before taking any trade on our charts / calls, please consult your financial advisors. Thanks
is Strong Performer development focused pharmaceutical company , today break 52w high with High volumes + high gain recorded .
This is my favorite chart pattern like "Cup and Handle " which is almost 80% successfully my side i believe on that for reached my targets' .
below some points of study for you like this ))-
Annual Revenue rose 37.57%, in the last year to Rs 2,811 Crores. Its sector's average revenue growth for the last fiscal year was 8.79%.
Company has been maintaining a healthy dividend payout of 28.0%
Holding :-
Promoter Holding :- 50%
FII :- 14%
DII :- 11 %
Public :- 25 %
give interim dividend
Ex-Date :- 26 Feb 2024
Dividend Amount :- 1.25
for MORE check in my TradingView ID
If You LIKE👌👌 MY Idea ......Boost.🔥🔥🔥.. its.
"Disclosure : I am not Sebi-registered." This channel is for only educational purpose. Any profit/loss, I am not responsible.
Before taking any trade on our charts / calls, please consult your financial advisors. Thanks
הערה
i share weekly chart pattern already check this .הערה
1st trg completeהערה
near2nd trg
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.